Hormones

Anisimov, VN, Zavarzina , N, Zabezhinski , M, Popovich , I, Zimina , O, Shtylick , A, Arutjunyan , A, Oparina , T, Prokopenko , V, Mikhalski , A & Yashin , A, 2001, ‘Melatonin Increases Both Life Span and Tumor Incidence in Female CBA Mice’, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol 56A, no 7, B311-B323.

Arwert, LI, Deijen, JB & Drent, ML, 2005, ‘The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis’, Growth Hormone & IGF Research, vol 15, issue 6, Pages 416- 422.

Barrett- Connor, E & Goodman-Gruen D, 1995, ‘The epidemiology of DHEAS and cardiovascular disease, Annals of the New York Academy of Sciences, vol 774, Pages 259-70.

Bartke, A, Coschigano, Karen, Kopchick, John, Chandrashekar, Varadaraj, Mattison, Julie, Kinney, Beth & Hauck, Steven, 2001, ‘Genes That Prolong Life: Relationships of Growth Hormone and Growth to Aging and Life Span’, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol 56A, no 8, B340-B349.

Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy M, Latour F, Leaud M, Mokrane A, Pitti-Ferrandi H, Trivalle H, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle J, Raison J, Le Bouc Y, Raynaud A, Girerd X, & Forette F, 2000, ‘Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEA Age Study to a sociobiomedical issue’, Proceedings of the National Academy of Sciences of the United States of America , vol 97, no 8, Pages 4279–84.

Borlu, M, Tanriverdi, F, Koc, CA, Unluhizarci, K, Utas, S & Kelestimur, F, 2007,The effects of severe growth hormone deficiency on the skin of patients with Sheehan’s syndrome’, Journal of the European Academy of Dermatology and Venereology, vol 21, issue 2, Page 199-204.

Burger, AG, Monson, JP, Colao, AM & Klibanski, A, 2006, ‘Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution’, Endocrine Practice, vol 12 no 6, Pages 682-689.

Casson, PR, Anderson, RN, Herrod, HG, Stentz, FB, Straughn, AB, Abraham, GE & Buster, JE, 1993, ;Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women’, American Journal of Obstetrics & Gynecology, vol 169(6), Pages 1536-9.

Clapp-Lilly, K.L., Smith, M.A., Perry, G., Harris, P.L., Zhu, X., and Duffy, L.K., 2001, ‘Melatonin acts as anti-oxidant and pro-oxidant in an organotypic slice culture model of Alzheimer’s Disease’, Neuroreport, vol 12, no 6, Pages 1277-1280.

Clemmons, ER, & Underwood, L, In: Underwood LE, (Ed), 1986, Human Growth Hormone: Progresses and Challenges, Marcel Dekker Inc., New York.

Deijen, JB, de Boer, H, Blok, GJ & van der Veen, RA, 1996, ‘Cognitive impairments and mood disturbances in growth hormone deficient men’, Psychoneuroendocrinology, vol 21, issue 3, Pages 313-322.

Diamond, P, Cusan, L, Gomez, J.L, Bélanger, A & Labrie, F, 1996, ‘Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women’, Journal of Endocrinology, vol 150, Pages S43–S50.

Fazio, S, 1996, ‘Preliminary study of growth hormone in the treatment of dilated cardiomyopathy’, New England Journal of Medicine, vol 334, Pages 809-814.

Gotherstrom, G, Bengtsson BA, Bosæus, I, Johannsson, G & Svensson, J, 2007, ‘BRIEF REPORT: A 10-Year, Prospective Study of the Metabolic Effects of Growth Hormone Replacement in Adults’, Journal of Clinical Endocrinology & Metabolism, Vol 92, issue 4, Pages 1442-1445.

Hughes, RJ, Sack, RL & Levy, RJ, 1998, ‘The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement’, Sleep, vol 21, Pages 52-68.

Hwangbo, Dae Sun, Gersham, Boris, Tu, Meng-Ping, Palmer, Michael & Tatar, Marc, 2004, ‘Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body’, Nature, vol 429, Pages 562-566.

Jessee, RL, Loesser K, Eich, DM, Qian, YZ, Hess ML & Nestler JE, 1995, ‘Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo’, Annals of the New York Academy of Sciences, vol 774, Pages 281-90.

Johansson, JO, Larson, G, Andersson, M, Elmgren, A, Hynsjö, L, Lindahl, A, Lundberg, P.-A, Isaksson, O.G.P, Lindstedt, S & Bengtsson, B.-Å, 1995, ‘Treatment of Growth Hormone-Deficient Adults with Recombinant Human Growth Hormone Increases the Concentration of Growth Hormone in the Cerebrospinal Fluid and Affects Neurotransmitters’, Neuroendocrinology, vol. 61, no. 1, Pages 57-66.

Jørgensen, Jens OL, Thuesen, Leif, Müller, Jørn, Ovesen, Per, Skakkebæk, Niels E, & Christiansen, Jens S, 1994, ‘Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance’, European Journal of Endocrinology, vol 130, issue 3, Pages 224- 228.

Kelley, KW, Brief, S, Westly, H J, Novakofski, J, Bechtel, PJ, Simon, J & Walker, EB, 1986, ‘GH3 pituitary adenoma cells can reverse thymic aging in rats’, Proceedings of the National Academy of Sciences of the United States of America , vol 83, no 15, Pages 5663-5667.

Kent, Saul, 2003, Life Extension Magazine http://www.lef.org/magazine/mag2003/2003_preprint_bio_02.html

Khorram, Omid, Vu, Lan & Yen S.C, 1997, ‘Activation of Immune Function by Dehydroepiandrosterone (DHEA) in Age-Advanced Men’, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 52A: M1-M7.

Konakchieva, R, Mitev, Y, Almeida, OF, Patchev, VK, 1998, Chronic melatonin treatment counteracts glucocorticoid-induced dysregulation of the hypothalamic- pituitary-adrenal axis in the rat’, Neuroendocrinology, vol 67, Pages 171-180.

Lenoir, V, 2005, ‘Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat’, Breast Cancer Research and Treatment, vol, 7(4):R470-R476.

Longo, VD & Finch, CE, 2003, ‘Evolutionary medicine: from dwarf model systems to healthy centenarians?’, Science, vol 299, Pages 1342-1346.

Lowy, Michael, 2009, in: The Australian Centre of Excellence in Male Reproductive Health www.andrologyaustralia.org

Luboshitzky, R, Levi, M, Shen-orr, Z, Blumenfeld, Z, Herer, P & Lavie, P, 2000, ‘Long-term melatonin administration does not alter pituitary-gonadal hormone secretion in normal men’, Human Reproduction, vol 15, no 1, Pages 60-65.

Mansouri, A, Demeilliers, Christine, Amsellem, Sabine, Pessayre, Dominique & Fromenty , Bernard , 2001, ‘Acute Ethanol Administration Oxidatively Damages and Depletes Mitochondrial DNA in Mouse Liver, Brain, Heart, and Skeletal Muscles: Protective Effects of Antioxidants’, Pharmacology and Experimental Therapeutics, vol. 298, issue 2, Pages 737-743.

McCraty, R, Barrios-Choplin, B, Rozman, D, Atkinson, M & Watkins, AD, 1998, ‘The Impact of a New Emotional Self-Management Program on Stress, Emotions, Heart Rate Variability, DHEA and Cortisol ‘, Integrative Physiological and Behavioral Science, vol 33, no 2, Pages 161-170.

Morales, AJ, Nolan, JJ, Nelson, JC & Yen, SS, 1994, ‘Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age’, Journal of Clinical Endocrinology & Metabolism, vol 78, Pages 1360-1367.

Mortola J & Yen SSC, 1990, ‘The effects of dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women’, Journal of Clinical Endocrinology & Metabolism, vol 71, Pages 695-704.

Nestler, J E, Barlascini, CO, Clore, JN & Blackard WG, 1988, ‘Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men’, Journal of Clinical Endocrinology & Metabolism, vol 66(1), Pages 57-61.

Osseni, RA, Rat, P, Bogdan, A, Warnet, J & Touitou, Y, 2001, ‘Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2’, Life Sciences, 502 Pages 127-131.

Pappolla M, Bozner, P, Soto, C, Shao, H, Robakis, N, Zagorski, M, Frangione, B & Ghiso, J, 1998 , ‘Inhibition of Alzheimer -Fibrillogenesis by Melatonin’, Journal of Biological Chemistry, vol 273, issue 13, Pages 7185-7188.

Petrie, K, Dawson, AG, Thompson L & Brook R, 1993, ‘A double-blind trial of melatonin as a treatment for jet lag in international cabin crew’, Biological Psychiatry, vol 33, Pages 526-530.

Pieri, C, Maurizio M, Moroni F, Recchioni R & Marcheselli F, 1994, ‘Melatonin: a peroxyl radical scavenger more effective than vitamin E’, Life Sciences: Pharmacology Letters, vol 55, no 15, Page 271-276.

Pierpaoli, W, Bulian, D, Bulian, G & Kistler, G, 1999, Thyrotropin-Releasing Hormone Accelerates and Enhances the Age-Postponing Effects of Melatonin’, Journal of Anti-Aging Medicine, Winter, Pages 343-348.

Pierpaoli, W & Regelson, W, 1994, ‘Pineal control of aging: effect of melatonin and pineal grafting on aging mice’, Proceedings of the National Academy of Sciences, vol 91, no 2, Pages 787-791.

Qi, W, Reiter, RJ, Tan, DX, Garcia, J, Manchester, L, Karbownik, M & Calvo, J, 2000, ‘Chromium(III)-Induced 8-Hydroxydeoxyguanosine in DNA and Its Reduction by Antioxidants: Comparative Effects of Melatonin, Ascorbate, and Vitamin E’, Environmental Health Perspectives, vol, 108, no 5, Pages 399-402.

Rao, GN, Ney E & Herbert, RA, 2000, ‘Effect of Melatonin and Linolenic Acid on Mammary Cancer in Transgenic Mice with c-neu Breast Cancer Oncogene’, Breast Cancer Research and Treatment, vol, 64, no 3, Pages 287-296.

Reiter, WJ, Pycha, A, Schatzl G, et al. 1999 ‘Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind randomized, placebo-controlled study’, Urology, vol 53, Pages 590-595.

Reiter, RJ & Tan, DX, 2003, ‘Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart’, Cardiovascular Research, vol 58, no 1, Pages 10-19.

Reiter, RJ, Tan, DX, Leon, J, Kilic, U & Kilic, E, 2005, ‘When Melatonin Gets on Your Nerves: Its Beneficial Actions in Experimental Models of Stroke’, Experimental Biology and Medicine, vol 230, no 2, Pages 104-117.

Rudman, D, Feller, AG, Nagraj, HS, Gergans, GA, Lalitha, PY, Goldberg, AF, Schlenker, RA , Cohn, L , Rudman, IW & Mattson DE, 1990, Effects of human growth hormone in men over 60 years old’, The New England Journal of Medicine, vol 323, Pages 1-6.

Sanchez-Barcelo, EJ, Cos, S, Fernandez, R & Mediavilla, MD, 2003, ‘Melatonin and mammary cancer: a short review’, Endocrine-Related Cancer, vol 10, issue 2, Pages 153-159.

Serrata, MA, Vinyard, CJ & King, D, 2007, ‘Alterations in the mechanical properties and composition of skin in human growth hormone transgenic mice’, Connective Tissue Research, vol 48, issue 1, Pages 19-26.

Wolkowitz, OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, & Roberts E, 1999, ‘Double-blind treatment of major depression with dehydroepiandrosterone’, The American Journal of Psychiatry, vol 156, Pages 646–649.

Yen SS, Morales AJ & Khorram, O, 1995, ‘Replacement of DHEA in aging men and women’, Annals of the New York Academy of Sciences, vol 774, Pages 128-142.

Zhadanova, IV, Wurtman, RJ & Lynch, HJ, 1995, ‘Sleep inducing effects of low doses of melatonin ingested in the evening’, Clinical Pharmacology & Therapeutics, vol 57, Pages 552-558.